Compound Radar

Cencora, Inc. (COR) Stock Analysis

United States · Healthcare / Medical Distribution

Price $324.69
Market cap $61.96B
Next earnings Nov 4, 2026
Entry status Watch $298.89–$317.37

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

58
58/100 Acceptable
  • Financial Health 65
  • Profitability 45
  • Business Quality 65
  • Balance Sheet 55
  • Cash Flow 60

Why this rating?

Health 58/100 — Acceptable

Strongest Financial Health 65/100
Softest Profitability 45/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

Cencora, Inc. (COR) is a Medical Distribution company in the Healthcare sector. Compound Radar rates Cencora, Inc. 58/100 (Acceptable) due to solid business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 24.1
  • Forward P/E 16.42
  • PEG 0.69
  • EV/Revenue 0.23

Profitability

  • Revenue Growth 5.1%
  • Gross Margin 4.0%
  • Operating Margin 1.4%
  • Net Margin 0.8%
  • ROE 96.9%

Financial strength

  • Cash $2.82B
  • Debt $14.46B
  • Net Cash $-11.65B
  • Free Cash Flow $3.21B
  • Current Ratio 0.94

Similar companies

Peers in Medical Distribution, ranked by Financial Health.

View all in Medical Distribution →

FAQ

How Compound Radar scores and tracks Cencora, Inc. (COR).

View Methodology & FAQ →